211 related articles for article (PubMed ID: 29342499)
21. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids.
Ramanan AV; Campbell-Webster N; Ota S; Parker S; Tran D; Tyrrell PN; Cameron B; Spiegel L; Schneider R; Laxer RM; Silverman ED; Feldman BM
Arthritis Rheum; 2005 Nov; 52(11):3570-8. PubMed ID: 16255046
[TBL] [Abstract][Full Text] [Related]
22. Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis.
Wienke J; Pachman LM; Morgan GA; Yeo JG; Amoruso MC; Hans V; Kamphuis SSM; Hoppenreijs EPAH; Armbrust W; van den Berg JM; Hissink Muller PCE; Gelderman KA; Arkachaisri T; van Wijk F; van Royen-Kerkhof A
Arthritis Rheumatol; 2020 Jul; 72(7):1214-1226. PubMed ID: 32103637
[TBL] [Abstract][Full Text] [Related]
23. Myelopathies secondary to Sjögren's syndrome: treatment with monthly intravenous cyclophosphamide associated with corticosteroids.
de Seze J; Delalande S; Fauchais AL; Hachulla E; Stojkovic T; Ferriby D; Hatron PY; Vermersch P
J Rheumatol; 2006 Apr; 33(4):709-11. PubMed ID: 16583474
[TBL] [Abstract][Full Text] [Related]
24. Treatment of polymyositis and dermatomyositis.
Kaye SA; Isenberg DA
Br J Hosp Med; 1994 Nov 2-15; 52(9):463-8. PubMed ID: 7874361
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Pediatric Takayasu arteritis with infliximab and cyclophosphamide: experience from an American-Brazilian cohort study.
Stern S; Clemente G; Reiff A; Ramos MP; Marzan KA; Terreri MT
J Clin Rheumatol; 2014 Jun; 20(4):183-8. PubMed ID: 24847743
[TBL] [Abstract][Full Text] [Related]
26. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis.
Constantin T; Ponyi A; Orbán I; Molnár K; Dérfalvi B; Dicso F; Kálovics T; Müller J; Garami M; Sallai A; Balogh Z; Szalai Z; Fekete G; Dankó K
Autoimmunity; 2006 May; 39(3):223-32. PubMed ID: 16769656
[TBL] [Abstract][Full Text] [Related]
27. Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies.
Moreno-Torres V; Martín-Iglesias D; Vivero F; González-Echavarri C; García-Moyano M; Enghelmayer JI; Malfante P; Gaser A; Ruiz-Irastorza G;
Semin Arthritis Rheum; 2023 Apr; 59():152164. PubMed ID: 36773521
[TBL] [Abstract][Full Text] [Related]
28. Treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey.
Stringer E; Bohnsack J; Bowyer SL; Griffin TA; Huber AM; Lang B; Lindsley CB; Ota S; Pilkington C; Reed AM; Scuccimarri R; Feldman BM
J Rheumatol; 2010 Sep; 37(9):1953-61. PubMed ID: 20595275
[TBL] [Abstract][Full Text] [Related]
29. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.
Oddis CV; Reed AM; Aggarwal R; Rider LG; Ascherman DP; Levesque MC; Barohn RJ; Feldman BM; Harris-Love MO; Koontz DC; Fertig N; Kelley SS; Pryber SL; Miller FW; Rockette HE;
Arthritis Rheum; 2013 Feb; 65(2):314-24. PubMed ID: 23124935
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of tacrolimus (FK-506) in the treatment of recalcitrant juvenile dermatomyositis: study of 6 cases].
Martín Nalda A; Modesto Caballero C; Arnal Guimeral C; Boronat Rom M; Barceló García P
Med Clin (Barc); 2006 Nov; 127(18):697-701. PubMed ID: 17169297
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy.
Niewold TB; Kariuki SN; Morgan GA; Shrestha S; Pachman LM
Arthritis Rheum; 2009 Jun; 60(6):1815-24. PubMed ID: 19479879
[TBL] [Abstract][Full Text] [Related]
32. Use of Rescue Therapy with IVIG or Cyclophosphamide in Juvenile Myositis.
Doudouliaki T; Papadopoulou C; Deakin CT
Curr Rheumatol Rep; 2021 Mar; 23(4):24. PubMed ID: 33686540
[TBL] [Abstract][Full Text] [Related]
33. Juvenile dermatomyositis with a rare and remarkable complication: sinus bradycardia.
Karaca NE; Aksu G; Yeniay BS; Kutukculer N
Rheumatol Int; 2006 Dec; 27(2):179-82. PubMed ID: 16944159
[TBL] [Abstract][Full Text] [Related]
34. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
[TBL] [Abstract][Full Text] [Related]
35. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Rider LG; Aggarwal R; Pistorio A; Bayat N; Erman B; Feldman BM; Huber AM; Cimaz R; Cuttica RJ; de Oliveira SK; Lindsley CB; Pilkington CA; Punaro M; Ravelli A; Reed AM; Rouster-Stevens K; van Royen-Kerkhof A; Dressler F; Magalhaes CS; Constantin T; Davidson JE; Magnusson B; Russo R; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J; Ruperto N;
Arthritis Rheumatol; 2017 May; 69(5):911-923. PubMed ID: 28382778
[TBL] [Abstract][Full Text] [Related]
36. Twelve years experience of juvenile dermatomyositis in North India.
Singh S; Bansal A
Rheumatol Int; 2006 Apr; 26(6):510-5. PubMed ID: 16163542
[TBL] [Abstract][Full Text] [Related]
37. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
[TBL] [Abstract][Full Text] [Related]
38. Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania.
Furia FF; Godfrey E; Mwamanenge N; Swai P
Pediatr Rheumatol Online J; 2020 Apr; 18(1):30. PubMed ID: 32245494
[TBL] [Abstract][Full Text] [Related]
39. Severe gastrointestinal inflammation in adult dermatomyositis: characterization of a novel clinical association.
Tweezer-Zaks N; Ben-Horin S; Schiby G; Bank I; Levi Y; Livneh A; Langevitz P
Am J Med Sci; 2006 Dec; 332(6):308-13. PubMed ID: 17170621
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
